ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

EPIX ESSA Pharma Inc

6.62
0.19 (2.95%)
2024年5月2日 - 終了
15分遅延
名称 銘柄コード 市場 種別
ESSA Pharma Inc EPIX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.19 2.95% 6.62 08:03:11
始値 安値 高値 終値 前日終値
6.46 6.43 7.13 6.62 6.43
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0921:00PRNCAESSA Pharma to Present at the 2024 Bloom Burton & Co...
2024/3/0810:13PRNUSESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING..
2024/3/0807:18EDGAR2Form 8-K - Current report
2024/3/0608:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1321:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/2/1321:01EDGAR2Form 8-K - Current report
2024/2/1321:00PRNUSESSA Pharma Provides Corporate Update and Reports Financial..
2024/2/0801:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0622:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0622:00PRNCAESSA Pharma to Present at the Oppenheimer 34th Annual..
2024/1/2923:15EDGAR2Form 8-K - Current report
2024/1/2706:40EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/1/2706:27EDGAR2Form DEF 14A - Other definitive proxy statements
2024/1/2600:00PRNUSESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386)..
2024/1/2406:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/1810:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1706:19EDGAR2Form 144 - Report of proposed sale of securities
2024/1/1703:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0910:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0606:04EDGAR2Form 144 - Report of proposed sale of securities
2023/12/1221:01EDGAR2Form 8-K - Current report
2023/12/1221:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2023/12/1221:00PRNCAESSA Pharma Provides Corporate Update and Reports Financial..
2023/11/2501:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2122:00PRNUSESSA Pharma to Present at the Piper Sandler 35th Annual..
2023/11/0822:00PRNCAESSA Pharma to Present at the Jefferies London Healthcare..
2023/11/0707:51PRNUSESSA Pharma Enters into At-The-Market Equity Offering Sales..
2023/11/0706:57EDGAR2Form 8-K - Current report
2023/10/2706:41PRNUSESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386)..
2023/10/2405:19EDGAR2Form 8-K - Current report
2023/10/2122:00PRNCAESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386)..
2023/10/1113:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/10/0405:35EDGAR2Form S-3/A - Registration statement under Securities Act of..
2023/9/2005:43EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/9/1820:05EDGAR2Form 8-K - Current report
2023/9/1820:00PRNUSESSA Pharma Announces Initiation of Phase 2 Study Evaluating..
2023/8/3120:00PRNCAESSA Pharma Insiders Establish Automatic Securities..
2023/8/0820:15EDGAR2Form 8-K - Current report
2023/8/0820:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0820:00PRNCAESSA Pharma Provides Corporate Update and Reports Financial..
2023/6/0620:00PRNUSESSA Pharma Appoints Lauren Merendino to its Board of..
2023/6/0120:00PRNUSESSA Pharma to Present at 2023 Jefferies Healthcare..
2023/5/1120:00PRNCAESSA Pharma to Present at JMP Securities Life Sciences..
2023/5/0920:00PRNUSESSA Pharma Provides Corporate Update and Reports Financial..

最近閲覧した銘柄

Delayed Upgrade Clock